Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
about
Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.Role of hemostatic factors in hepatic injury and disease: animal models de-liver.Non-alcoholic fatty liver disease-From the cardiologist perspective.Pediatric transplantation: preventing thrombosis.Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place.
P2860
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@ast
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@en
type
label
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@ast
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@en
prefLabel
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@ast
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@en
P2093
P1433
P1476
Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?
@en
P2093
Greg C G Hugenholtz
Patrick G Northup
Robert J Porte
P304
P356
10.1016/J.BLRE.2014.10.002
P50
P577
2014-11-01T00:00:00Z